COST-EFFECTIVENESS ANALYSIS OF AUGMENTIN 625 MG AND AUCLANITYL 500 MG/125 MG IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA. YHCĐ. 2026;67(CD15). doi:10.52163/yhc.v67iCD15.6792